In a phase II trial, 29 patients with anthracycline-pretreated or anthracycline-resistant metastatic breast cancer in whom anthracycline-containing first- or second-line chemotherapy failed received combination paclitaxel
Bruno Cortes Aragão, MD
Advertisement
Articles by Bruno Cortes Aragão, MD
Advertisement
Latest Updated Articles
- Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer
Published: February 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
3
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
4
FDA Approves Revumenib in R/R NPM1-Mutant AML
5
